Đang chuẩn bị liên kết để tải về tài liệu:
Synthesis, biological evaluation and molecular docking studies of 6-(4-nitrophenoxy)-1H-imidazo[4,5-b] pyridine derivatives as novel antitubercular agents: future DprE1 inhibitors

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Tuberculosis is an air-borne disease, mostly affecting young adults in their productive years. Here, Ligand-based drug design approach yielded a series of 23 novel 6-(4-nitrophenoxy)-1H-imidazo[4,5-b]pyridine derivatives. | Synthesis biological evaluation and molecular docking studies of 6- 4-nitrophenoxy -1H-imidazo 4 5-b pyridine derivatives as novel antitubercular agents future DprE1 inhibitors

TÀI LIỆU LIÊN QUAN

Synthesis, molecular docking and biological evaluation of bis-pyrimidine Schiff base derivatives

Antimicrobial and anticancer activity of some novel fluorinated thiourea derivatives carrying sulfonamide moieties: Synthesis, biological evaluation and molecular docking

4-Thiazolidinone coumarin derivatives as two-component NS2B/NS3 DENV favivirus serine protease inhibitors: Synthesis, molecular docking, biological evaluation and structure - activity relationship studies

Design, synthesis, biological evaluation and molecular docking of novel molecules to PARP-1 enzyme

Synthesis, biological evaluation and molecular docking analysis of vaniline– benzylidenehydrazine hybrids as potent tyrosinase inhibitors

Synthesis, biological evaluation, and molecular docking of N′ -(Aryl/alkylsulfonyl)-1-(phenylsulfonyl) piperidine-4-carbohydrazide derivatives

Design, synthesis, and preliminary biological evaluation of catalpol propionates as antiaging drugs

Synthesis, computational drug likeness, DFT studies and in vitro biological activity evaluation of some heteronuclear complexes of functionalized (E)-2-(butan-2-ylidene) hydrazinecarbothioamide ligand

Synthesis, characterization, biological evaluation and molecular docking studies of 2-(1H-benzo[d] imidazol-2-ylthio)-N-(substituted 4-oxothiazolidin-3-yl) acetamides

Design, synthesis, and biological evaluation of novel N4 -substituted sulfonamides: Acetamides derivatives as dihydrofolate reductase (DHFR) inhibitors